This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (2)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

LAWRENCE PETERS, M.D.

AMA Arch Intern Med. 1956;98(4):409-415.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In the absence of more extensive knowledge concerning the etiology of essential and malignant hypertension, current attempts at their management with drugs necessarily consist of symptomatic therapy. Such therapy is directed largely toward lowering the elevated blood pressure, either for short periods of time and on isolated occasions when a hypertensive crisis is present or imminent or on a more continuous schedule with day-to-day medication. The principles upon which such symptomatic treatment are based are (1) that reduction of the elevated pressure may reduce symptoms and cardiac work and may prevent retinal and cerebral hemorrhages; (2) that it may prevent or retard progressive arteriolar injury and thus intensification of the disease process.

The purpose of this pharmacological discussion is not to evaluate the concept of using hypotensive agents in the therapy of hypertension or to assess the therapeutic value of the procedure. Rather it is to outline briefly the known . . . [Full Text PDF of this Article]

Author Affiliations
Kansas City, Kan.

From the Department of Pharmacology, University of Kansas Medical Center.

Footnotes
Read before the Section on Experimental Medicine and Therapeutics Symposium on Management of Hypertension at the 105th Annual Meeting of the American Medical Association, Chicago, June 12, 1956.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?